ISM-8207

N/A

Report date: 2024/05/16 14:40:09
NME

Base Information

Drug NameISM-8207
Drug Alias NameISM8207ISM-8207
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutaminyl-peptide cyclotransferase-like protein inhibitors
TargetsGlutaminyl-peptide cyclotransferase-like protein
Therapy Area/IndicationsSolid tumoursLymphoma, B-CellNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesInsilico Medicine Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesInsilico Medicine LtdInSilico Medicine Hong Kong Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursLymphoma, B-Cell
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A